← Back to Abbott India Ltd. overview
Abbott India Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹6,407 cr | ₹1,414 cr | ₹665.62 | ₹5,917 cr | ₹4,233 cr | 33.41% | 42.85% | 0.05x | 22.08% |
| FY2024 | ₹5,847 cr | ₹1,201 cr | ₹565.28 | ₹5,193 cr | ₹3,699 cr | 32.48% | 43.1% | 0.02x | 20.54% |
| FY2023 | ₹5,347 cr | ₹949 cr | ₹446.78 | ₹4,556 cr | ₹3,189 cr | 29.78% | 39.06% | 0.04x | 17.76% |
| FY2022 | ₹4,910 cr | ₹799 cr | ₹375.86 | ₹4,224 cr | ₹2,820 cr | 28.32% | 36.98% | 0.05x | 16.27% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.